DRUG ALERT
CLASS 3 MEDICINES RECALL
Action within five days
PHARMACY OR EQUIVALENT LEVEL RECALL
| 13 September 2012 | EL (12)A/30 |
Our ref:
MDR 02-09/12 |
Dear Healthcare Professional,
ratiopharm GmbH
AllerTek 10mg Tablets
(Cetirizine dihydrochloride)
| Batch Number | Expiry Date | Pack Size | First Distributed |
| L04664 | 31 January 2014 | 1 x 14 (GSL) | 31 March 2011 |
Teva UK Limited is recalling all remaining stock of the above batch. This is because the results of dissolution tests carried out during routine stability studies did not comply with the required specification.
Remaining stocks of this batch should be quarantined and returned to the original supplier for credit. For further stock enquiries please contact Teva UK Customer Liaison Team on 0800 590502
For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email at medinfo@tevauk.com
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary care trusts are asked to forward this to relevant clinics and to general practitioners and community pharmacists for information.
Alison Bunce
Pharmaceutical Assessor, DMRC MHRA Distribution (further recipients by cascade): Regional Contacts for NHS Trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison health policy unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to independent health care establishments
Primary care trusts (England)
Class 3 Drug Alert (Action within five days): AllerTek 10mg Tablets - Teva UK Limited - EL (12)A/30 
